DEPLOYDatabase

Robot model

CorPath GRX

surgicalcommercialby Corindus Vascular Robotics

Corindus Vascular Robotics CorPath GRX robotic vascular intervention system.

Track CorPath GRX
Manufacturer
Corindus Vascular Robotics
Form factor
surgical
Maturity
commercial
Lifecycle
active

The verified answer

As of Oct 2026, DEPLOY verifies CorPath GRX, a surgical by Corindus Vascular Robotics (commercial). 2 sources back the record.

Deploy Watch

Track CorPath GRX on Deploy.

We notify you when a verified state change lands on the record, not when the company issues a claim.

Track CorPath GRX

Key facts

Siemens Healthineers acquisition (company-stated, Aug 2019)

Siemens Healthineers agreed on Aug 8 2019 to acquire Corindus Vascular Robotics for $4.28 a share in cash, about $1.1 billion in total.

Markets (company-stated)

CorPath systems remotely control guide catheters, wires, balloons and stents for coronary, peripheral vascular and, outside the U.S. for some indications, neurovascular use.

Function (FDA 510(k))

Robotically manipulates guidewires, rapid-exchange catheters and guide catheters during percutaneous vascular procedures.

Remote cockpit (FDA 510(k))

A bedside unit with robotic drive components and a remote interventional cockpit used by the physician during the procedure.

Data & sources

Government records

1

Web sources

1

2 sources backing this record.View all →

Pricing

No verified price is on record for CorPath GRX. Physical-AI systems are often sold through enterprise contracts or operated as a service rather than at a public list price.

How DEPLOY tracks pricing

Recent activity

Every change to this record is dated, sourced, and independently verified where marked.

Full change history →

Safety record

No incidents on record for CorPath GRX.

Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.

Sources (2)

  1. https://www.siemens-healthineers.com/en-us/press-room/press-releases/pr-20190808032shs.html
  2. https://www.accessdata.fda.gov/cdrh_docs/pdf20/K202275.pdf

Mentioned on (2)

Registry pages whose text names CorPath GRX.

Common questions

What is CorPath GRX?
Corindus Vascular Robotics CorPath GRX robotic vascular intervention system.
How much does CorPath GRX cost?
CorPath GRX's price is not publicly disclosed. DEPLOY has no verified price on record for CorPath GRX from Corindus Vascular Robotics. Physical-AI systems like this are often sold through enterprise contracts or operated as a service rather than at a public list price; check the manufacturer for the latest.
Is CorPath GRX actually deployed in the real world?
CorPath GRX is recorded at the commercial stage, but DEPLOY has no deployment verified at a named site yet; vendor deployment claims are not independently confirmed here. Manufacturer capability claims should be read as claims pending independent verification.
Who makes CorPath GRX?
CorPath GRX is made by Corindus Vascular Robotics, based in USA.
Can you buy CorPath GRX?
CorPath GRX is in commercial deployment and is sold to operators; contact the manufacturer to buy, and see the pricing section for any recorded price.
What are alternatives to CorPath GRX?
On the DEPLOY registry, comparable surgical robots to CorPath GRX include da Vinci (and Ion), Edge Multi-Port Surgical Robot, Edison Histotripsy System, Stryker Mako SmartRobotics.
How does CorPath GRX compare to da Vinci (and Ion)?
CorPath GRX and da Vinci (and Ion) (Intuitive Surgical · 15 deployments) are both surgical robots on the DEPLOY registry. CorPath GRX has 0 verified deployments on record. Compare both records for specs, safety, deployments, and verified-vs-claimed autonomy.
Is CorPath GRX a top surgical?
On DEPLOY's intelligence score, which blends verified deployments, safety, adoption, media, and IP signals, CorPath GRX ranks in roughly the top 72% of surgical models tracked by the registry.
What is CorPath GRX's maturity stage?
CorPath GRX is at the commercial stage on the DEPLOY maturity ladder (research, prototype, pilot, commercial, production). Commercial stage means production-grade deployments are operating at named customer sites.
Where is CorPath GRX deployed?
No verified deployments of CorPath GRX are currently on the DEPLOY registry. DEPLOY records deployments only when verified at a named site with a primary source; absence may reflect pre-deployment, research, or manufacturer-internal use.
Is CorPath GRX safe?
CorPath GRX has no incidents on record in the DEPLOY registry. This does not constitute a safety guarantee; it reflects the incidents DEPLOY has tracked and verified to date.
Methodology: Verified · 2 sources (1 primary) · last reviewed 2026-10-10

Verification posture

Verified

High confidence

Review state

Stable

Last reviewed 2026-10-10

Maturity + lifecycle

Maturity stage: commercial

Lifecycle: active

Architectural position

Cohort: surgical

Sources by quality tier

1
unclassified
Unclassified source
1
primary-fda-database
FDA database

The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.

Methodology surface for CorPath GRX.

Recent coverage

CorPath GRX in third-party press

Robotic PCI confirmed to be both safe and effective in new comprehensive analysis

May 16, 2025

Siemens Calls It Quits in Cardiovascular Surgical Robotics

May 10, 2023

Stroke International Services (SIS) General Hospital installs Corindus CorPath® GRX system to enhance its endovascular care program

Sep 15, 2022